Ftse Mib
33.167,64
0,00%
DAX
19.304,88
0,00%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
93.550,01
1,72%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Spero Therapeutics Inc (SPRO) Spero Therapeutics Inc (SPRO) Notizie

Spero Therapeutics Inc

SPRO
1,101
-0,049 (-4,26%)
27 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:05GLOBESpero Therapeutics Announces Third Quarter 2024 Operating..
12/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05GLOBESpero Therapeutics to Report Third Quarter 2024 Financial..
29/10/202422:01EDGAR2Form 8-K - Current report
29/10/202421:05GLOBESpero Therapeutics Announces SPR720 Phase 2a Interim Results..
16/10/202422:05GLOBESpero Therapeutics Announces Presentation of SPR719 (Active..
02/10/202422:30GLOBESpero Therapeutics Announces Publication of SPR720 Phase 1..
10/9/202412:56EDGAR2Form 8-K - Current report
04/9/202422:05GLOBESpero Therapeutics to Present at Upcoming September Investor..
30/8/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202422:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/8/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202422:13EDGAR2Form 8-K - Current report
05/8/202422:01GLOBESpero Therapeutics Announces Second Quarter 2024 Operating..
29/7/202422:05GLOBESpero Therapeutics to Report Second Quarter 2024 Financial..
03/7/202419:05GLOBESpero Therapeutics Announces Inducement Grant Under Nasdaq..
03/6/202422:15EDGAR2Form 8-K - Current report
30/5/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202413:50IHMARKETNEWSU.S. Index Futures Flat Ahead of April CPI Data Release, Oil..
06/3/202414:05GLOBESpero Therapeutics to Provide Business Update and Report..
28/2/202414:05GLOBESpero Therapeutics Announces Clearance of IND for SPR206 to..
26/2/202414:05GLOBESpero Therapeutics to Present at Cowen’s 44th Annual..
09/2/202422:05EDGAR2Form 8-K - Current report
06/2/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:50EDGAR2Form 144 - Report of proposed sale of securities
31/1/202422:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
08/1/202412:07EDGAR2Form 8-K - Current report
05/1/202414:11EDGAR2Form 8-K - Current report
05/1/202414:05GLOBESpero Therapeutics Provides Corporate Update and 2024..
04/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:13EDGAR2Form 8-K - Current report
02/1/202414:05GLOBESpero Therapeutics Announces First Patient, First Visit for..
Apertura: 1,16 Min: 1,10 Max: 1,17
Chiusura: 1,15

La tua Cronologia

NASDAQ
SPRO
Spero Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network